Navigation Links
EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC)
Date:5/29/2012

PALO ALTO, Calif., May 29, 2012 /PRNewswire/ -- EQUICARE CS, a cancer survivorship case management software program jointly offered by Varian Medical Systems (NYSE: VAR) and Equicare Health, Inc., has been included by the American College of Surgeons Commission on Cancer (CoC) in its "Best Practices Repository." The repository is a list of resources designed to help cancer treatment centers in the U.S. adopt rigorous standards for high-quality patient-centered care, in order to qualify to become CoC-accredited cancer programs.

There are over 13 million cancer patients currently living in the U.S., and the number is expected to grow to 18 million by 2020. Only a very small number of cancer treatment centers are set up to deliver survivorship care once treatment is over. Nevertheless, after treatment for cancer, many patients require post-treatment follow-up care for late effects of treatment, secondary cancers, and quality of life issues. Some need further diagnostic testing, or nutritional and counseling services. 

"Cancer survivors benefit most when they have access to coordinated post-treatment care," said Malcolm Wright, vice president of product management at Equicare Health. "Therefore, the CoC has mandated that all organizations seeking their accreditation will have to create a formal plan for delivering survivorship care by 2014, and they will have to implement that plan by 2015. EQUICARE CS can help them comply with these requirements."

According to the American College of Surgeons, CoC accreditation is a voluntary commitment by a cancer program that ensures patients will have access to a full scope of services required to diagnose, treat, rehabilitate, and support patients with cancer and their families. By 2015, all CoC-accredited institutions will have to produce survivorship care plans for each of their patients, in
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Cannulas Market by ... Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & ... Forecast to 2020" report to their offering. ... to grow at a CAGR of 5.6% from ...
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Pharmaceuticals, Inc. (NASDAQ GM: AERI )? , Did you ... inclusive? , Did you lose money in your investment in ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3
... , NORCROSS, Ga., Nov. 23 Immucor, Inc. (Nasdaq: ... to the blood transfusion industry, today announced that access to ... Conference in New York, NY will be available via a ... scheduled for Tuesday, December 1, 2009, at 12:30 p.m. Eastern ...
... RICHMOND, Calif., Nov. 23 Transcept Pharmaceuticals, Inc. (Nasdaq: ... with the U.S. Food and Drug Administration (FDA) on January ... New Drug Application (NDA) for Intermezzo ® ... Letter, received by Transcept on October 28, 2009, indicated that ...
Cached Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2
(Date:5/6/2015)... 2015 Baptist Medical Center Jacksonville ... in north Florida and southeast Georgia region offering ... innovation in total hip replacement surgery performed using ... arm that enables the accurate alignment and positioning ... offered MAKOplasty® partial knee resurfacing using the RIO ...
(Date:5/6/2015)... 06, 2015 “ SideChef ” was featured on ... at the latest and coolest applications on the market for iOS, ... expert, conducted the app review and shared with viewers how this ... day when to be a good navigator people had to know ... now everyone is a master navigator. Well what if people could ...
(Date:5/6/2015)... Anitha Nallari, MD has joined ... Inc. in Columbus, OH. Dr. Nallari will see patients ... in breast cancer, lung cancer, GI and gallbladder cancer, head ... benign hematology. , Dr. Anitha Nallari is Board ... American Board of Internal Medicine. She completed her medical education ...
(Date:5/6/2015)... Follow us on LinkedIn ... by the rising consumer awareness over the importance of ... Hand washing is becoming a part of personal hygiene ... infections. Periodic outbreak of Avian flu, Swine flu, and ... disease (EVD) epidemic in West Africa are mega ...
(Date:5/6/2015)... has opened press registration for TU-Automotive Detroit as the ... headlines of major publications world-wide. With 150+ speakers from ... to share their visions for the future of connected ... to go behind the scenes and hear major automakers’ ... year we’re releasing a preview of all the major ...
Breaking Medicine News(10 mins):Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:Press Registration for TU-Automotive Detroit Now Open 2
... a major advance in the treatment of prostate cancer, scientists ... tea inhibit cancer growth. This new discovery, published online in ... antioxidants in red wine and green tea produce a combined ... prostate cancer growth. This finding is important because it may ...
... PHOENIX, Ariz. June 9, 2010 Joshua Niska, a ... a string of major academic honors today by being named ... TODAY. Niska and other members of the national newspaper,s ... $2,500 cash award. They were selected, according to the newspaper, ...
... may make a new, experimental anti-cancer drug effective against a ... at Chicago College of Medicine have found. A man-made ... to cause tumor cells to die while leaving normal cells ... one of the chemical building blocks of DNA. Andrei Gartel, ...
... assisted reproduction (MAR) have fiscal implications for government both ... Based on public funding to conceive a MAR child ... costs, and future tax contributions of this child - ... government spending and tax revenue) of a child born ...
... are associated with increased teenage car crash rates, according to ... 2010, in San Antonio, Texas, at SLEEP 2010, the 24th ... Results indicate that in 2008 the teen crash rate was ... school classes began at 7:20 a.m., than in adjacent Chesapeake, ...
... blood vessel-blocking drug called tasquinimod slowed the rate of ... cancer patients, according to experts at Johns Hopkins, Roswell ... a so-called "anti-angiogenesis" drug that squeezes off blood supply ... Tumors require these vast networks of blood vessels ...
Cached Medicine News:Health News:Polyphenols in red wine and green tea halt prostate cancer growth 2Health News:TGen intern named one of nation's top 20 students by USA Today 2Health News:TGen intern named one of nation's top 20 students by USA Today 3Health News:Compound enhances cancer-killing properties of agent in trials 2Health News:Is IVF good value for money? Why funding of assisted reproduction is sound fiscal policy 2Health News:Is IVF good value for money? Why funding of assisted reproduction is sound fiscal policy 3Health News:Teen automobile crash rates are higher when school starts earlier 2Health News:Drug that restricts blood supply to prostate tumors delays disease progression 2
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Designated most popular model or size. 3 mm tip....
Designated most popular model or size. Slightly angled, 2 mm wide....
Medicine Products: